You are here

Approvals, Launches, and New Indications

Efficacy shown in GO-VIBRANT and GO-ALIVE studies
Treatment targets relapsed or refractory large B-cell lymphoma
Senhance System aids surgeons in minimally invasive procedures
New indication follows study showing significant skin clearance at week 12
Siemens Magnetom Terra doubles available magnetic field strength
Investigational peptide vaccine induces attack on various cancers
One-time treatment eases pain for 12 weeks
Device targets moderate-to-severe central sleep apnea
Device billed as smallest, lightest responsive therapy for drug-resistant epilepsy
Cobas Zika test is made by Roche Molecular Systems
Two formulations of MS drug earn Teva more than $4 billion
The inhaled therapy treats fungal infections in the lungs
In trial, 14.3% of patients responded to the drug
New indication targets advanced cases with PD-L1 expression
Easier-to-clean Pentax device may help limit bacterial infections
First once-daily, single-inhaler triple therapy for the disease in the U.S.
Proprietary delivery system deposits proven steroid deep into the nose
Injection is also approved for GEP-NETs
Single-dose oral therapy treats leading gynecological infection
Approval based on totality of evidence from global development program showing Mvasi is highly similar to Genentech’s Avastin